SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

CASI Pharmaceuticals, Inc. – ‘8-K’ for 6/12/14 – EX-3.1

On:  Friday, 6/13/14, at 8:00am ET   ·   For:  6/12/14   ·   Accession #:  1144204-14-37444   ·   File #:  0-20713

Previous ‘8-K’:  ‘8-K’ on 6/3/14 for 6/2/14   ·   Next:  ‘8-K’ on / for 8/14/14   ·   Latest:  ‘8-K’ on 3/21/23 for 3/20/23

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 6/13/14  CASI Pharmaceuticals, Inc.        8-K:5,8,9   6/12/14    3:90K                                    Vintage/FA

Current Report   —   Form 8-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 8-K         Current Report                                      HTML     23K 
 2: EX-3.1      Articles of Incorporation/Organization or By-Laws   HTML      9K 
 3: EX-99.1     Miscellaneous Exhibit                               HTML     14K 


EX-3.1   —   Articles of Incorporation/Organization or By-Laws


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 

Exhibit 3.1

 

CERTIFICATE OF AMENDMENT

TO

AMENDED AND RESTATED

CERTIFICATE OF INCORPORATION

OF

ENTREMED, INC.

 

(Pursuant to Section 242 of the General Corporation Law)

 

EntreMed, Inc., a Delaware corporation (the “Corporation”), does hereby certify:

 

1.          The name of the Corporation is EntreMed, Inc.

 

2.          The Corporation filed a Certificate of Incorporation with the Office of the Secretary of State of the State of Delaware on September 18, 1991. The Corporation filed an Amended and Restated Certificate of Incorporation (the “Certificate”) with the Office of the Secretary of State of the State of Delaware on July 11, 2002.

 

3.          At a meeting of directors held on March 12, 2014, the Board of Directors of the Corporation unanimously adopted a resolution recommending to the Corporation’s stockholders the advisability of adopting an amendment to Article I of the Certificate to read, in its entirety, as follows:

 

“I.

 

 The name of the corporation is: CASI Pharmaceuticals, Inc. (hereinafter the “Corporation”).”

 

4.          At the annual meeting of the Corporation’s stockholders held on June 12, 2014, the holders of a majority of the shares of the Corporation’s common stock voted to approve the amendment to the Certificate as set forth in Paragraph 3 above.

 

5.          The amendment to the Certificate has been duly adopted in accordance with the requirements of Section 242 of the General Corporation Law of the State of Delaware, and shall be effective at 8:00 a.m. on Monday, June 16, 2014.

 

IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be duly executed and attested by its duly authorized officers this 12th day of June, 2014.

 

Attest:   EntreMed, Inc.
       
/s/ Cynthia W. Hu   By: /s/ Ken K. Ren
Cynthia W. Hu, Corporate Secretary     Ken K. Ren, Chief Executive Officer

 

 

 


Dates Referenced Herein   and   Documents Incorporated by Reference

This ‘8-K’ Filing    Date    Other Filings
6/16/14
Filed on:6/13/14
For Period End:6/12/14DEF 14A
3/12/14
7/11/02
 List all Filings
Top
Filing Submission 0001144204-14-037444   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Tue., May 14, 3:50:36.1pm ET